EEF2K and melanoma: Results showed that EEF2K silencing increased the percentage of apoptotic cells and cell arrest in the G0/G1 phase in both SK‐MEL‐28 and A375 melanoma cells, and decreased the cell percentage in S and G2/M phases (Figure 1D–F and Figure S1G,H).